Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, October 30 - Friday, November 3, 2023), and click each link to read and watch anything you may have missed.
1.) Advantages of delaying embryo transfer after pregnancy loss
In a recent study, women with an interpregnancy interval under 3 months, more often had worse pregnancy outcomes compared to those with an interval of 3 to under 6 months or of 6 to 12 months.
Click here for the full article.
2.) Prenatal fentanyl exposure and a novel syndrome
In a recent study, physical abnormalities were seen among children born from pregnancies complicated by fentanyl.
Click here for the full article.
3.) Utility of pelvic ultrasound imaging in diagnosing endometriosis
Findings and significance for gynecologic surgeons.
Click here for the full article.
4.) Artificial intelligence for embryo evaluation
In a recent study, models for embryo evaluation using artificial intelligence had strong accuracy.
5.) Misoprostol alone effective for abortion
In a recent story, a completed abortion was reported in 98.6% of patients taking a misoprostol alone regimen.
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Understanding VTE and bleeding risks in gynecologic noncancer surgery
April 15th 2024Delve into the nuanced risks of venous thromboembolism and major bleeding post-gynecologic noncancer surgery, exploring procedure-specific variations and the implications for thromboprophylaxis strategies.
Read More
